[go: up one dir, main page]

AR037908A1 - Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus - Google Patents

Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus

Info

Publication number
AR037908A1
AR037908A1 ARP020104953A ARP020104953A AR037908A1 AR 037908 A1 AR037908 A1 AR 037908A1 AR P020104953 A ARP020104953 A AR P020104953A AR P020104953 A ARP020104953 A AR P020104953A AR 037908 A1 AR037908 A1 AR 037908A1
Authority
AR
Argentina
Prior art keywords
biomass
production
virus antigens
avian embryo
embryo particles
Prior art date
Application number
ARP020104953A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR037908A1 publication Critical patent/AR037908A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proporciona una biomasa que comprende partículas de embrión aviar que tienen un tamano de partícula de aproximadamente 0,5 mm a 10,0 mm y el uso de la misma en un método para la producción de antígenos de virus. También proporciona un método para la preparación de una vacuna útil para el mejoramiento y prevención de enfermedades virales.
ARP020104953A 2001-12-21 2002-12-18 Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus AR037908A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34333901P 2001-12-21 2001-12-21

Publications (1)

Publication Number Publication Date
AR037908A1 true AR037908A1 (es) 2004-12-22

Family

ID=23345706

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104953A AR037908A1 (es) 2001-12-21 2002-12-18 Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus

Country Status (18)

Country Link
US (3) US20040023358A1 (es)
EP (2) EP2157173A1 (es)
JP (1) JP2005514018A (es)
KR (1) KR20040070250A (es)
CN (1) CN100408675C (es)
AR (1) AR037908A1 (es)
AU (1) AU2002360659B2 (es)
BR (1) BR0215013A (es)
CA (1) CA2471131A1 (es)
CO (1) CO5590972A2 (es)
HR (1) HRP20040641A2 (es)
HU (1) HU225995B1 (es)
MX (1) MXPA04005888A (es)
NZ (1) NZ534070A (es)
PL (1) PL371381A1 (es)
RS (1) RS55404A (es)
TW (1) TWI267553B (es)
WO (1) WO2003055988A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8237946B2 (en) * 2004-10-08 2012-08-07 Sharp Laboratories Of America, Inc. Methods and systems for imaging device accounting server redundancy
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638985A5 (de) * 1979-04-10 1983-10-31 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
CA2192994A1 (en) * 1994-06-20 1995-12-28 Henry D. Stone In ovo immunization of avian embryos with oil-emulsion vaccines
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
JP3490536B2 (ja) * 1995-04-21 2004-01-26 株式会社ブリヂストン 空気入りラジアルタイヤ
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
MXPA04005888A (es) 2004-09-13
RS55404A (sr) 2006-10-27
CO5590972A2 (es) 2005-12-30
PL371381A1 (en) 2005-06-13
US20090226487A1 (en) 2009-09-10
CN100408675C (zh) 2008-08-06
CN1604961A (zh) 2005-04-06
TW200301305A (en) 2003-07-01
NZ534070A (en) 2006-01-27
EP2157173A1 (en) 2010-02-24
JP2005514018A (ja) 2005-05-19
US20040023358A1 (en) 2004-02-05
BR0215013A (pt) 2004-11-09
AU2002360659B2 (en) 2009-01-08
KR20040070250A (ko) 2004-08-06
HUP0402548A2 (hu) 2005-03-29
HU225995B1 (en) 2008-02-28
WO2003055988A1 (en) 2003-07-10
AU2002360659A1 (en) 2003-07-15
EP1458851A1 (en) 2004-09-22
HRP20040641A2 (en) 2004-10-31
CA2471131A1 (en) 2003-07-10
TWI267553B (en) 2006-12-01
US20080102507A1 (en) 2008-05-01

Similar Documents

Publication Publication Date Title
DE60121136D1 (de) Proteasom-influenzavirus-impfstoffzusammensetzung
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
ATE539765T1 (de) Grippeimpfstoffe mit kombinationen aus teilchenförmigen adjuvantien und immunverstärkern
ECSP045300A (es) Antígenos virales
CY1108789T1 (el) Καθαρισμος αντιγονων hbv για χρηση σε εμβολια
EP1485468A4 (en) RECOMBINANT PARAIN FLUENZAVIRUS EXPRESSION SYSTEMS AND VACCINES WITH ANTIGENS FROM METAPNEUMOVIRUS STEM-RELATED HETEROLOGISTS
CO5540349A2 (es) Preparacion vacunal de virus de influenza inactivado
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
AR032597A1 (es) Uso de antigenos del virus de la gripe inactivado, en la preparacion de vacunas de una sola dosis intranasal; metodo para la profilaxis de enfermedades o de infecciones gripales en pacientes; equipos que comprenden dichas vacunas en dosis unicas y metodo para fabricar vacunas para la gripe para apli
AR040177A1 (es) Sal de formiato de o-desmetil-venlafaxina
AU2003246373A1 (en) Recombinant measles viruses expressing epitopes pf antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions
EA200701633A1 (ru) Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
MX2022006742A (es) Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter.
ATE455124T1 (de) Rekombinante vesicular stomatitis viren als impstoff gegen virale hämorrhagische fieber
ATE383871T1 (de) Gebrauch von opri lipoprotein aus pseudomonas als th1 induzierendes natürliches adjuvans für heterologe antigene
AR037908A1 (es) Una biomasa en particulas de embrion aviar para la produccion de antigenos de virus
AR023534A1 (es) Vacuna.
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
ATE471990T1 (de) Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln
AR054259A1 (es) Vacuna contra virus de papiloma humano (hpv)
WO2003032917A3 (en) Hookworm vaccine
AR016987A1 (es) Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a

Legal Events

Date Code Title Description
FB Suspension of granting procedure